Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, part 2: Consensus statement for anaesthesia practice

Feldheiser, A. ; Aziz, O. ; Baldini, G. ; Cox, B. P. B. W. ; Fearon, K. C. H. ; Feldman, L. S. ; Gan, T. J. ; Kennedy, R. H. ; Ljungqvist, O. ; Lobo, D. N. ; Miller, T. ; Radtke, F. F. ; Ruiz Garces, T. ; Schricker, T. ; Scott, M. J. ; Thacker, J. K. ; Ytrebø, L. M. ; Carli, F.

Resumen: Background The present interdisciplinary consensus review proposes clinical considerations and recommendations for anaesthetic practice in patients undergoing gastrointestinal surgery with an Enhanced Recovery after Surgery (ERAS) programme. Methods Studies were selected with particular attention being paid to meta-analyses, randomized controlled trials and large prospective cohort studies. For each item of the perioperative treatment pathway, available English-language literature was examined and reviewed. The group reached a consensus recommendation after critical appraisal of the literature. Results This consensus statement demonstrates that anaesthesiologists control several preoperative, intraoperative and postoperative ERAS elements. Further research is needed to verify the strength of these recommendations. Conclusions Based on the evidence available for each element of perioperative care pathways, the Enhanced Recovery After Surgery (ERAS ®) Society presents a comprehensive consensus review, clinical considerations and recommendations for anaesthesia care in patients undergoing gastrointestinal surgery within an ERAS programme. This unified protocol facilitates involvement of anaesthesiologists in the implementation of the ERAS programmes and allows for comparison between centres and it eventually might facilitate the design of multi-institutional prospective and adequately powered randomized trials.

Idioma: Inglés

DOI: 10.1111/aas.12651

Año: 2016

Publicado en: ACTA ANAESTHESIOLOGICA SCANDINAVICA 60, 3 (2016), 289-334
ISSN: 0001-5172

Factor impacto JCR: 2.438 (2016)

Categ. JCR: ANESTHESIOLOGY rank: 14 / 31 = 0.452 (2016) - Q2 - T2

Factor impacto SCIMAGO: 0.98 - Medicine (miscellaneous) (Q1) - Anesthesiology and Pain Medicine (Q1)

Tipo y forma: Article (Published version)